Match Document Document Title
US20060246129 Composition for use in treatment of sleep problems and method for same  
The present invention provides a non-addictive composition for the treatment of sleep disorders and problems including melatonin, valerian root extract, an antioxidant component, and a vitamin...
US20120177729 SUSTAINED RELEASE COMPOSITION OF RANOLAZINE  
The present invention relates to sustained release dosage form of Ranolazine or pharmaceutically acceptable salt(s), polymorph(s), solvate(s), hydrate(s), enantiomer(s) thereof which comprises a...
US20100247632 STABILIZED SOLUBILITY-ENHANCED FORMULATIONS FOR ORAL DELIVERY  
Methods and compositions are described whereby poorly water-soluble beneficial agents such as vitamins and co-factors are formulated into self-emulsifying formulas (SEF) and optionally sorbing the...
US20090092658 NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS  
The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability,...
US20130216616 CUSTOMIZED POLYPILLS HAVING HIGH DRUG LOADS  
Patient-specific polypills, or similar drug products with potential to benefit from reduced need for bulking agent and preferably having multiple active ingredients, producible via appropriately...
US20110177162 DEGRADABLE MICROCAPSULES  
The invention relates to microcapsules consisting of a polymer degradable by a polypeptide comprising a drug or other compound of interest and a genetically engineered cell expressing said...
US20120219620 SCF Extract Containing Cardiac Glycoside  
A supercritical fluid (SCF) extract of a cardiac glycoside-containing plant mass is provided. The extract can be included in a pharmaceutical composition containing an extract-solubilizing amount...
US20140308344 METHODS FOR TREATING MULTIPLE MYELOMA WITH 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE AFTER STEM CELL TRANSPLANTATION  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20060039966 Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same  
Disclosed herein are methods for improving user acceptance of an oral dosage form containing an active ingredient for use as a supplement and/or medicament by masking undesirous flavors, odors,...
US20050163833 Production of starch-gel-based shaped bodies  
Starch gels and a method for the production of shaped bodies therefrom containing active ingredients, especially gelatin-free soft capsules. Significant improvements, especially with regard to...
US20050249800 System for release in lower gastrointestinal tract  
A system whereby a substance which is orally taken and to be delivered into the lower digestive tract is selectively delivered into the lower digestive tract. More particularly, a system which...
US20130022670 Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration  
An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability...
US20090098198 Satiety  
A capsule for suppressing appetite, comprising: a) a shell which dissolves in the stomach; andb) a plurality of elements inside the shell, which elements expand inside the stomach, after the shell...
US20120034297 Pharmaceutical dosage forms comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine  
A pharmaceutical dosage form for administration twice daily, once daily or less frequently, which contains 6′-fluoro-(N-methyl- or...
US20090053303 MEDICAL FOOD OR NUTRITIONAL SUPPLEMENT, METHOD OF MANUFACTURING SAME, AND METHOD OF MANAGING DIABETES  
A medical food and/or nutritional supplement for oral administration by mammals includes α-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the...
US20130089602 ENCAPSULATED CHELATOR  
An enhanced chelator includes a chelating agent and a volatile material encapsulated in a biologically benign microcapsule. The enhanced chelator possesses significantly improved shelf-life in...
US20070207199 APPETITE SUPPRESSION DEVICE  
An appetite suppression device includes an ingestible, expandable membrane in surrounding an expandable reactant material. The membrane is contained in a capsule. A reactant enabling mechanism is...
US20110150985 METHODS FOR PREPARING PHARMACEUTICALS BY EMULSION AGGREGATION PROCESSES  
A method for making a pharmaceutical by emulsion aggregation, the method including emulsifying a first pharmaceutical agent and a biodegradable resin to form a primary emulsion of pre-aggregated...
US20140050783 METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS  
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or more disorders involving...
US20050143362 Danazol for treatment of hypogonadism in the adult male  
The method of use of danazol for enhancing the testosterone activity in the adult male. In particular, androgen activity levels are increased in the adult male suffering from hypogonadism by...
US20150250727 Synergistic Effect of Poloxamer-based Composition and Itraconazole on Fungus and Yeast  
A pharmaceutical composition for the treatment of yeast and fungal infections is provided. The composition may include a micronized poloxamer composition as excipient and itraconazole as active...
US20090246274 PHARMACEUTICAL COMPOSITION 271  
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoi midazole-5-carboxylic acid...
US20060099248 5,6,7-Trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses  
Compositions containing 5,6,7-trihydroxyheptanoic acid and analogs and their use for treating posterior segment ocular diseases and diseases characterized by cellular hyperproliferation or...
US20140356422 STABLE PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF  
The present invention relates to a pharmaceutical formulation for oral administration for preventing or treating allergic rhinitis or asthma, which comprises: (a) a first particle part comprising...
US20130266643 Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis  
Described herein are compositions comprising glyceryl-triacetate (GTA) for use in delivering non-glucose energy deriving metabolites during physical performance, which reduce lactate production...
US20060275520 White peony extract for improving the duration and quality of sleep  
The present invention relates to compositions for treating insomnia or sleeplessness. The compositions of the present invention comprise extracts of white peony root and in particular comprise...
US20130022673 ENHANCEMENT OF MAGNESIUM UPTAKE IN MAMMALS  
Disclosed are methods and complexes for increasing magnesium uptake in mammals. Increasing magnesium uptake in mammals is accomplished by concurrently administering one or more magnesium salts...
US20150224075 OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH  
A formulation for treating omega-3 fatty acid deficiency is disclosed containing about 90% or more omega 3 fatty acids by weight comprised of a combination of Eicosapentaenoic acid (EPA),...
US20070048365 Edible coded microsubstrate for pharmaceuticals  
A system for verifying product authenticity. A verification system may include: coded microstructures contained within a product. In particular implementations, such as pharmaceuticals, the...
US20050266069 Stable probiotic microsphere compositions and their methods of preparation  
The invention relates to viable and stable probiotic formulations for intestinal targeting made of microspheres comprising each a core of one or more probiotic bacteria, microcrystallline...
US20120288559 ORGANIC COMPOUNDS  
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition...
US20150086622 GROWTH ENHANCEMENT OF INFANTS  
The present invention relates to compositions and methods for enhancing the growth of infants. Particularly, the present invention discloses the use of insulin for promoting the growth of low...
US20120045505 FIXED DOSE DRUG COMBINATION FORMULATIONS  
Pharmaceutical formulations comprising multiple drugs, for treating or preventing cardiovascular disease. Embodiments are capsules containing individual drugs, or combinations of drugs, in the...
US20120141584 Multilayer Minitablets  
Multilayer minitablets for oral administration of an active pharmaceutical ingredient which release the active pharmaceutical ingredient at different pH ranges and/or in different release profiles...
US20080081066 Tea-Derived Compositions and Methods of Using Same for Cardiovascular Health  
Disclosed herein are compositions comprising tea derived components which are useful in decreasing elevated blood pressures, lowering LDL and/or lowering inflammatory markers of cardiovascular...
US20080160075 Pharmaceutical Composition Made From Chinese Traditional Medicine And Method Of Producing Thereof  
A method of preparing a Chinese medicine for treatment of diabetes, the medicine including the Radix Rehmanniae Preparata, prepared Asiatic Comelian Cherry fruit, tree peony bark, Common Yam...
US20100203118 COLLAPSIBLE WATER-CONTAINING CAPSULES  
Collapsible water-containing capsules comprising by weight: (a) from about 40% to about 95% of a water phase the water phase comprising at least 50% water by weight of the water phase; and (b)...
US20100021535 LIGHT-STABILIZED SOFT CAPSULE FORMULATIONS  
An object of the present invention is to provide a small-sized light-stabilized soft capsule formulation, which has a shell that ensures effective light shielding of an active ingredient...
US20130315988 Pharmaceutical Composition  
A composition comprising rifaximin in the form of particles, wherein substantially all the particles have a particle size less than or equal to 2 micrometres.
US20140234391 LOCATION-SPECIFIC BACTERIAL MANAGEMENT  
A method for reducing the population of pathogenic bacteria in an animal being reared in an animal rearing facility is provided. The method involves using one or more than one naturally-occurring...
US20150150829 CAPSULES CONTAINING THYMOQUINONE  
This invention relates to stable capsule formulations for pharmaceutical, nutraceuticals or food supplements which contain thymoquinone (THQ) as an active ingredient, and which can be stored at...
US20070031486 Nutritional supplement for use under physiologically stressful conditions  
A nutritional supplement to be incorporated into the diet of an individual experiencing physiologically stressful conditions is described.
US20090169608 TOPICALLY APPLICABLE COMPOSITION FOR USE AS A SKIN BLEACHING AGENT  
Topical composition for use especially as a skin lightener, characterized in that it contains an effective amount of at least one compound of general formula (I) or a mixture of such compounds...
US20100215732 INGESTIBLE IMPLEMENT FOR WEIGHT CONTROL  
An orally administrable implement for expanding in a stomach of an animal, including a mammal, to fill a space in the stomach, is provided for weight control. The implement includes: a...
US20080138402 Highly inhibited starch fillers for films and capsules  
The invention provides the addition of highly inhibited starch filler to gelatin-free films and soft capsules. The addition of the highly inhibited starch filler raises the solid levels during...
US20080075765 METHODS AND MATERIALS FOR REDUCING RISK OF COLD AND/OR FLU  
Disclosed herein are compositions comprising tea derived components which are useful in reducing the incidence of cold and/or flu in a subject. Specifically exemplified herein are compositions...
US20120276194 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF  
The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil,...
US20110135719 PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF  
The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil,...
US20140199382 STABLE PHARMACEUTICAL COMPOSITIONS OF AN S1P RECEPTOR AGONIST  
The present invention relates to a stable pharmaceutical composition comprising an S1P receptor agonist and one or more pharmaceutically acceptable excipients, wherein the composition is free of a...
US20050165000 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant  
Pharmaceutical compositions comprise a therapeutically effective amount of an 8-hydroxy-1,6-naphthyridine-7-carboxamide of Formula (I), or a pharmaceutically acceptable salt thereof: and a...